A phase 1, first-in-human, dose-escalation study of JNJ-74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

1. Searle,E.
2. Cluzeau,T.
3. O'Nions,J.
4. Recher,C.
5. Gyan,E.
6. Morillo,D.
7. Esteve,J.
8. Kulasekararaj,A.
9. Raffoux,E.
10. Walter,H.S.
11. Pigneux,A.
12. Valcárcel,D.
13. Daskalakis,N.
14. Bussolari,J.
15. Pietsch,E.C.
16. Kuduk,S.
17. Bush,T.
18. Zhang,X.
19. Philippar,U.
20. Oluwasanjo,A.
21. Bradford,K.
22. Miller,J.
23. Van Bogaert,C.
24. Curtis,M.
25. Chang,S.-Y.
26. Guttke,C.
27. Gaj,S.
28. Pearson,R.
29. Murphy,J.
30. van Dijck,W.
31. Alfonso Piérola,A.
32. Show all authors +

Export

Export ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export ×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/BJH.20224 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus